Gaps in surveillance, testing, sequencing and vaccination are continuing to create perfect conditions for a new COVID-19 variant of concern to emerge: WHO
Geneva: The World Health Organization (WHO) has once again alerted lapses in strategies to tackle Covid-19 this year continue to create the perfect conditions for a "deadly new variant" to emerge.
"WHO estimates that at least 90% of the world’s population now has some level of immunity to SARS-CoV-2, due to prior infection or vaccination. We are much closer to being able to say that the emergency phase of the pandemic is over – but we’re not there yet," WHO Director-General Tedros Adhanom Ghebreyesus said during a media interaction.
"Gaps in surveillance, testing, sequencing and vaccination are continuing to create the perfect conditions for a new variant of concern to emerge that could cause significant mortality," he said.
COVID-19 pandemic hit the world late in 2019 and showed its deadly form in 2020.
Even now, several Chinese cities have been put under lockdown to tackle the virial infection.
IBNS
Senior Staff Reporter at Northeast Herald, covering news from Tripura and Northeast India.
Related Articles
CK Birla Hospitals launches massive cervical cancer fight: 5,000 women set to receive life-saving HPV vaccine!
Kolkata/IBNS: In line with its commitment to the #FightAgainstCervicalCancer, CK Birla Hospitals has intensified its cervical cancer vaccination drive, with an initial aim of administering 5,000 Human Papillomavirus (HPV) vaccines.
Want to exercise more? Study says the secret starts with your sleep
Getting enough sleep and staying active are two of the most important things we can do for our health, but new research shows that most people struggle to achieve both, and that sleep may hold the key to moving more.
India gears up for a global health showdown as 2nd WHO Traditional Medicine Summit Nears!
The Ministry of Ayush on Monday organized a Curtain Raiser Press Conference at the National Media Centre, New Delhi, ahead of the 2nd WHO Global Summit on Traditional Medicine, to be held from December 17–19 at Bharat Mandapam, New Delhi, where representatives of 100 countries are expected to attend.
Baldness battle may be over: New drug shows stunning results in phase III trial
Cosmo Pharmaceuticals N.V, an AI-powered healthcare and speciality pharma, has announced a compelling topline results from its two pivotal Phase III trials of clascoterone 5% topical solution for male androgenetic alopecia (AGA, also known as male-pattern hair loss), marking a potential first major therapeutic breakthrough in hair-loss treatment in more than three decades.
Latest News
CBI books Anil Abani's son Jai Anmol in Rs 228 crore bank fund misuse
Team Mohta annexes Ruia Gold Cup title, defeats team Hemant Jalan
NY mayor-elect Zohran Mamdani to move into Gracie Mansion; cites family safety, focus on ‘affordability agenda’
Bankim Chandra’s family decries Bengal govt's ‘neglect’, welcomes Modi’s tribute to ‘Vande Mataram’
